Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23775961

Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Aug 10
First author
Zukin M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Aug 10;31(23):2841-3. doi: 10.1200/JCO.2013.50.1502.
    note
    Source null
    related pmid
    23835705
    relationship
    Comment in

Authors and identifiers

  1. name
    Zukin M
    type
    Author
  2. name
    Barrios CH
    type
    Author
  3. name
    Pereira JR
    type
    Author
  4. name
    Ribeiro Rde A
    type
    Author
  5. name
    Beato CA
    type
    Author
  6. name
    do Nascimento YN
    type
    Author
  7. name
    Murad A
    type
    Author
  8. name
    Franke FA
    type
    Author
  9. name
    Precivale M
    type
    Author
  10. name
    Araujo LH
    type
    Author
  11. name
    Baldotto CS
    type
    Author
  12. name
    Vieira FM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Zukin M
    type
    Author
  2. name
    Barrios CH
    type
    Author
  3. name
    Pereira JR
    type
    Author
  4. name
    Ribeiro Rde A
    type
    Author
  5. name
    Beato CA
    type
    Author
  6. name
    do Nascimento YN
    type
    Author
  7. name
    Murad A
    type
    Author
  8. name
    Franke FA
    type
    Author
  9. name
    Precivale M
    type
    Author
  10. name
    Araujo LH
    type
    Author
  11. name
    Baldotto CS
    type
    Author
  12. name
    Vieira FM
    type
    Author
bibliography ids
  1. nci-bib-6940c5cda5dd551028b8028f
book metadata
content sha256
a0be26ae7d8ad2e29ce4c50b4c0dc4dc423edd61d8052ca6341ff861c812cd48
document type
citation
dois
  1. 10.1200/JCO.2012.48.1911
electronic publication date
display
2013 Jun 17
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23775961
immutable id
pubmed:23775961@a0be26ae7d8ad2e29ce4c50b4c0dc4dc423edd61d8052ca6341ff861c812cd48
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
23
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2849-53
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Aug 10;31(23):2841-3. doi: 10.1200/JCO.2013.50.1502.
    note
    Source null
    related pmid
    23835705
    relationship
    Comment in
outcomes validated
false
pmid
23775961
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
6c510353b7e4d5251d6f8ffaa18b97b5555c235f7c4d7f166083f120729ec597
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Aug 10
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23775961/
title
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.

Preserved source evidence · Not medical advice